Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ATEL Capital Group is a diversified financial services firm headquartered in San Francisco that provides equipment leasing, venture debt, and asset management services. Through its specialized division, ATEL Ventures, the company offers growth capital and financing solutions specifically tailored for venture-backed companies in the life sciences, biotechnology, and medical technology sectors. ATEL does not develop its own therapeutic products; instead, it serves as a strategic financial partner that helps emerging healthcare companies acquire essential laboratory and manufacturing equipment while preserving equity. Since its founding in 1976, the firm has financed a wide array of high-growth startups, supporting the infrastructure needs of the broader healthcare ecosystem. Its portfolio includes significant investments in clinical-stage biotech firms and medical device innovators across North America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ATEL Capital.